share_log

HC Wainwright & Co. Maintains Buy on Timber Pharmaceuticals, Lowers Price Target to $1

HC Wainwright & Co. Maintains Buy on Timber Pharmaceuticals, Lowers Price Target to $1

HC Wainwright & Co.维持对木材制药的买入,将目标价下调至1美元
Benzinga Real-time News ·  2022/10/26 06:32

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Timber Pharmaceuticals (AMEX:TMBR) with a Buy and lowers the price target from $1.5 to $1.

HC Wainwright & Co. 分析师拉古拉姆·塞尔瓦拉朱维持Timber Pharmicals(AMEX: TMBR)的买入,并将目标股价从1.5美元下调至1美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发